- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/35 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
Patent holdings for IPC class C07C 311/35
Total number of patents in this class: 17
10-year publication summary
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19544 |
6 |
| Amyris, Inc. | 379 |
4 |
| Hoffmann-La Roche Inc. | 3277 |
1 |
| AMOREPACIFIC Corporation | 2786 |
1 |
| Amydis Diagnostics, Inc. | 2 |
1 |
| Fibrotech Therapeutics PTY LTD | 7 |
1 |
| Galderma Research & Development | 416 |
1 |
| Ind-Swift Laboratories Limited | 57 |
1 |
| The Board of Regents of the University of Texas System | 2132 |
1 |
| Other owners | 0 |